MedPath

Clopidogrel

These highlights do not include all the information needed to use CLOPIDOGREL TABLETS safely and effectively. See full prescribing information for CLOPIDOGREL TABLETS. CLOPIDOGREL tablets for oral use Initial U.S. Approval: 1997

Approved
Approval ID

4cd07a3c-9673-4aa0-b76a-d79df2399ee1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 28, 2023

Manufacturers
FDA

Major Pharmaceuticals

DUNS: 191427277

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

clopidogrel bisulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0904-6467
Application NumberANDA076274
Product Classification
M
Marketing Category
C73584
G
Generic Name
clopidogrel bisulfate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 28, 2023
FDA Product Classification

INGREDIENTS (11)

CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CLOPIDOGREL BISULFATEActive
Quantity: 300 mg in 1 1
Code: 08I79HTP27
Classification: ACTIM
METHYLCELLULOSE (15 MPA.S)Inactive
Code: NPU9M2E6L8
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
ZINC STEARATEInactive
Code: H92E6QA4FV
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
HYDROXYPROPYL CELLULOSE (70000 WAMW)Inactive
Code: 66O7AQV0RT
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.